Results 171 to 180 of about 1,848 (184)

A Special Focus on Selexipag - Treatment of Pulmonary Arterial Hypertension

Current Pharmaceutical Design, 2018
Ulf Simonsen, Daniela Grimm, Markus Wehland   +2 more
exaly  

A pharmacokinetic drug–drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects

European Journal of Clinical Pharmacology, 2017
Jasper Dingemanse, Pierre-Eric Juif, Shirin Bruderer   +2 more
exaly  

Selexipag/Treprostinil

Reactions Weekly
openaire   +1 more source

Selexipag Dosing Strategies for Pediatric Patients with Pulmonary Arterial Hypertension

Pediatric Cardiology
E Zachary Ramsey
exaly  

Macitentan/Riociguat/Selexipag

Reactions Weekly
openaire   +1 more source

SOLID STATE FORMS OF SELEXIPAG

2017
VILLALVA NIDIA, CANTE IVON, AYBAR MARTIN, RODRIGUEZ ANGEL, TORRES ALEJANDRO GUILLEN, KANTOR HANA, GAVENDA ALES, HERRERA HUGO, JEGOROV ALEXANDER, LOPEZ NYDIA   +9 more
openaire   +3 more sources

PHARMACEUTICAL COMPOSITION COMPRISING SELEXIPAG

2018
HELLERBRAND KLAUS, SCHLICKER-SPAIN ALEXANDRA   +1 more
openaire   +4 more sources

PROCESS FOR THE PREPARATION OF SELEXIPAG

2017
MATHAD VIJAYAVITTHAL THIPPANNACHAR, DODDAPPA PRALHAD ANEKAL, KARDILE PRITESH BHIMRAJ, PADAKI SANTHOSH AMBADAS, GAIKWAD BAPUSAHEB SHRIHARI, SHINDE GORAKSHANATH BALASAHEB   +5 more
openaire   +1 more source

Selexipag/tadalafil/treprostinil

Reactions Weekly
openaire   +1 more source

METHODS FOR TRANSITIONING TO SELEXIPAG

2020
ZHAO CAROL, COLVIN RIESEN JOHANNA, PALMER GARY, KEATING MICHAEL, HARTLINE BRIAN, BENTON WADE, DUMITRESCU CAMELIA, SHAH MEHUL   +7 more
openaire   +1 more source